Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: February 3, 2026, 1:46 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 500696 | NSE: HINDUNILVR

Hindustan Unilever Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: February 3, 2026, 1:46 am

Market Cap 5,53,763 Cr.
Current Price 2,357
Intrinsic Value₹1,902.26
High / Low 2,660/2,044
Stock P/E52.4
Book Value 207
Dividend Yield1.82 %
ROCE27.8 %
ROE20.7 %
Face Value 1.00
PEG Ratio12.57

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Hindustan Unilever Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Honasa Consumer Ltd 8,920 Cr. 275 334/19071.7 38.80.00 %7.44 %5.51 % 10.0
Ambica Agarbathies Aroma & Industries Ltd 41.0 Cr. 23.9 37.0/22.380.4 65.20.00 %7.49 %0.45 % 10.0
Ador Multi Products Ltd 114 Cr. 119 149/23.4 32.50.00 %11.4 %3.09 % 10.0
Kaya Ltd 513 Cr. 346 488/204 60.90.00 %2.50 %% 10.0
Jyothy Labs Ltd 8,855 Cr. 241 423/23924.2 55.81.45 %24.6 %19.0 % 1.00
Industry Average69,618.07 Cr1,866.6453.37112.700.84%29.21%23.91%4.94

All Competitor Stocks of Hindustan Unilever Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 15,14415,59715,21515,49615,62315,56715,21015,70715,92615,81815,67016,51416,241
Expenses 11,66511,90311,64311,83211,82811,90211,67511,96512,13912,12312,05212,79712,515
Operating Profit 3,4793,6943,5723,6643,7953,6653,5353,7423,7873,6953,6183,7173,726
OPM % 23%24%23%24%24%24%23%24%24%23%23%23%23%
Other Income 80724014617818430920920374017174331
Interest 2829295088911059311011280127129
Depreciation 272293291286297313320329338341347361358
Profit before tax 3,2593,3793,4923,4743,5883,4453,4193,5293,5423,9823,3623,3033,570
Tax % 18%27%26%26%26%27%25%26%27%25%26%16%25%
Net Profit 2,6702,4812,6012,5562,6572,5082,5612,6122,5952,9892,4752,7682,694
EPS in Rs 11.3410.5311.0710.8711.3010.6810.8911.1111.0312.7010.4911.7311.43

Last Updated: January 2, 2026, 6:03 pm

Below is a detailed analysis of the quarterly data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Sales, as of Sep 2025, the value is 16,241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16,514.00 Cr. (Jun 2025) to 16,241.00 Cr., marking a decrease of 273.00 Cr..
  • For Expenses, as of Sep 2025, the value is 12,515.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12,797.00 Cr. (Jun 2025) to 12,515.00 Cr., marking a decrease of 282.00 Cr..
  • For Operating Profit, as of Sep 2025, the value is 3,726.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,717.00 Cr. (Jun 2025) to 3,726.00 Cr., marking an increase of 9.00 Cr..
  • For OPM %, as of Sep 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 23.00%.
  • For Other Income, as of Sep 2025, the value is 331.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Jun 2025) to 331.00 Cr., marking an increase of 257.00 Cr..
  • For Interest, as of Sep 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 127.00 Cr. (Jun 2025) to 129.00 Cr., marking an increase of 2.00 Cr..
  • For Depreciation, as of Sep 2025, the value is 358.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 361.00 Cr. (Jun 2025) to 358.00 Cr., marking a decrease of 3.00 Cr..
  • For Profit before tax, as of Sep 2025, the value is 3,570.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,303.00 Cr. (Jun 2025) to 3,570.00 Cr., marking an increase of 267.00 Cr..
  • For Tax %, as of Sep 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 16.00% (Jun 2025) to 25.00%, marking an increase of 9.00%.
  • For Net Profit, as of Sep 2025, the value is 2,694.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,768.00 Cr. (Jun 2025) to 2,694.00 Cr., marking a decrease of 74.00 Cr..
  • For EPS in Rs, as of Sep 2025, the value is 11.43. The value appears to be declining and may need further review. It has decreased from 11.73 (Jun 2025) to 11.43, marking a decrease of 0.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: December 15, 2025, 5:45 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 29,23431,97232,18633,16235,54539,31039,78347,02852,44660,58061,89663,12164,243
Expenses 24,47526,56026,27626,83428,04630,43029,92235,40239,58946,43347,23748,27849,487
Operating Profit 4,7595,4125,9106,3287,4998,8809,86111,62612,85714,14714,65914,84314,756
OPM % 16%17%18%19%21%23%25%25%25%23%24%24%23%
Other Income 7921,2474866063533224241702194488171,3221,316
Interest 411817352633118117106114334395448
Depreciation 2963223534325205651,0021,0741,0911,1371,2161,3551,407
Profit before tax 5,2156,3206,0266,4677,3068,6049,16510,60511,87913,34413,92614,41514,217
Tax % 24%31%31%31%28%30%26%25%25%24%26%26%
Net Profit 3,9564,3764,1514,4905,2276,0606,7567,9998,89210,14310,28210,67110,926
EPS in Rs 18.2420.1719.1820.6824.0927.9731.1734.0337.7943.0743.7445.3246.35
Dividend Payout % 71%74%83%82%83%78%80%119%90%91%96%117%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)10.62%-5.14%8.17%16.41%15.94%11.49%18.40%11.16%14.07%1.37%3.78%
Change in YoY Net Profit Growth (%)0.00%-15.76%13.31%8.25%-0.48%-4.45%6.91%-7.23%2.90%-12.70%2.41%

Hindustan Unilever Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:10%
3 Years:6%
TTM:3%
Compounded Profit Growth
10 Years:11%
5 Years:9%
3 Years:5%
TTM:3%
Stock Price CAGR
10 Years:13%
5 Years:5%
3 Years:1%
1 Year:-6%
Return on Equity
10 Years:29%
5 Years:21%
3 Years:20%
Last Year:21%

Last Updated: September 4, 2025, 9:25 pm

Balance Sheet

Last Updated: February 1, 2026, 12:16 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 216216216216216216216235235235235235235
Reserves 3,3213,8116,3576,5287,0657,6518,01347,43948,82650,06950,98349,16748,481
Borrowings 4643177277-099-0-01,0431,2191,4841,6481,775
Other Liabilities 10,17110,3598,0438,68510,58110,66311,92421,06620,40221,55425,78728,81331,543
Total Liabilities 13,75414,43014,79315,70617,86218,62920,15368,74070,50673,07778,48979,86382,034
Fixed Assets 2,7462,8213,2584,4194,5284,7155,47951,44351,47352,67853,74454,33558,126
CWIP 3735164082294614065977451,3131,1321,0251,0091,022
Investments 2,8383,0252,5923,7942,8732,7161,2552,7093,5212,8824,6253,8103,958
Other Assets 7,7978,0678,5357,26410,00010,79212,82213,84314,19916,38519,09520,70918,928
Total Assets 13,75414,43014,79315,70617,86218,62920,15368,74070,50673,07778,48979,86382,034

Below is a detailed analysis of the balance sheet data for Hindustan Unilever Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2025, the value is 235.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 235.00 Cr..
  • For Reserves, as of Sep 2025, the value is 48,481.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49,167.00 Cr. (Mar 2025) to 48,481.00 Cr., marking a decrease of 686.00 Cr..
  • For Borrowings, as of Sep 2025, the value is 1,775.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,648.00 Cr. (Mar 2025) to 1,775.00 Cr., marking an increase of 127.00 Cr..
  • For Other Liabilities, as of Sep 2025, the value is 31,543.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28,813.00 Cr. (Mar 2025) to 31,543.00 Cr., marking an increase of 2,730.00 Cr..
  • For Total Liabilities, as of Sep 2025, the value is 82,034.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..
  • For Fixed Assets, as of Sep 2025, the value is 58,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 54,335.00 Cr. (Mar 2025) to 58,126.00 Cr., marking an increase of 3,791.00 Cr..
  • For CWIP, as of Sep 2025, the value is 1,022.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,009.00 Cr. (Mar 2025) to 1,022.00 Cr., marking an increase of 13.00 Cr..
  • For Investments, as of Sep 2025, the value is 3,958.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,810.00 Cr. (Mar 2025) to 3,958.00 Cr., marking an increase of 148.00 Cr..
  • For Other Assets, as of Sep 2025, the value is 18,928.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,709.00 Cr. (Mar 2025) to 18,928.00 Cr., marking a decrease of 1,781.00 Cr..
  • For Total Assets, as of Sep 2025, the value is 82,034.00 Cr.. The value appears strong and on an upward trend. It has increased from 79,863.00 Cr. (Mar 2025) to 82,034.00 Cr., marking an increase of 2,171.00 Cr..

Notably, the Reserves (48,481.00 Cr.) exceed the Borrowings (1,775.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +3,8183,2924,1715,1856,0595,8007,6239,1639,0489,99115,46911,886
Cash from Investing Activity +-475138-282-1,173-1,063-4381,791-1,228-1,728-1,484-5,3246,473
Cash from Financing Activity +-2,960-3,462-3,864-4,214-4,975-5,390-6,819-9,309-8,015-8,953-10,034-13,101
Net Cash Flow383-3325-20221-282,595-1,374-695-4461115,258

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-42.00-38.00-172.00-271.007.00-91.009.0011.0011.0013.0013.0013.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days131214121317111416191822
Inventory Days867775676559656665555559
Days Payable170148156164185166176163145123143152
Cash Conversion Cycle-72-60-67-85-107-90-101-83-64-50-70-71
Working Capital Days-54-53-26-35-37-30-31-32-22-15-22-33
ROCE %147%139%112%91%103%116%117%39%25%27%27%28%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters61.90%61.90%61.90%61.90%61.90%61.90%61.90%61.90%61.90%61.90%61.90%61.90%
FIIs14.32%14.36%14.48%13.90%13.65%12.67%11.87%12.17%11.43%10.62%10.18%10.79%
DIIs11.50%11.51%11.47%11.90%12.31%13.21%14.09%14.13%14.67%15.48%15.99%15.62%
Government0.04%0.04%0.04%0.04%0.04%0.04%0.05%0.05%0.06%0.07%0.07%0.07%
Public12.23%12.17%12.09%12.26%12.11%12.19%12.11%11.75%11.94%11.93%11.86%11.62%
No. of Shareholders11,18,43111,27,98210,96,27011,76,41111,32,96512,05,41612,10,98911,05,25412,18,00112,33,43811,67,94510,95,447

Shareholding Pattern Chart

No. of Shareholders

Hindustan Unilever Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
ICICI Prudential Value Fund 7,610,705 2.88 1762.565,507,6352026-01-26 00:48:3838.18%
Nippon India Large Cap Fund 5,035,752 2.29 1166.23N/AN/AN/A
SBI Large Cap Fund 4,590,000 1.9 1063N/AN/AN/A
ICICI Prudential Multi Asset Fund 3,546,157 1.05 821.253,225,5602026-01-26 00:48:399.94%
Nippon India Small Cap Fund 2,743,992 0.93 635.482,121,4612026-01-26 00:48:3929.34%
ICICI Prudential Equity Savings Fund 2,701,878 3.46 625.732,027,0712026-01-26 00:41:0733.29%
Kotak Flexicap Fund 2,600,000 1.07 602.13N/AN/AN/A
Mirae Asset Large Cap Fund 2,249,564 1.25 520.982,303,3452026-01-26 00:48:39-2.33%
ICICI Prudential India Opportunities Fund 2,245,126 1.5 519.952,786,8722026-01-26 00:48:39-19.44%
ICICI Prudential Equity & Debt Fund 2,235,251 1.04 517.66N/AN/AN/A

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 45.3243.7443.0737.7934.03
Diluted EPS (Rs.) 45.3243.7443.0737.7934.03
Cash EPS (Rs.) 51.2148.9448.0042.4838.61
Book Value[Excl.RevalReserv]/Share (Rs.) 210.22217.95214.99208.88202.95
Book Value[Incl.RevalReserv]/Share (Rs.) 210.22217.95214.99208.88202.95
Revenue From Operations / Share (Rs.) 268.60263.39257.79223.17200.12
PBDIT / Share (Rs.) 67.5265.8562.3955.8151.22
PBIT / Share (Rs.) 61.7660.6757.5551.1746.65
PBT / Share (Rs.) 61.3759.2856.7950.5345.13
Net Profit / Share (Rs.) 45.4443.7743.1737.8434.04
NP After MI And SOA / Share (Rs.) 45.3143.7343.0637.7834.02
PBDIT Margin (%) 25.1325.0024.2025.0025.59
PBIT Margin (%) 22.9923.0322.3222.9223.30
PBT Margin (%) 22.8422.5022.0322.6422.55
Net Profit Margin (%) 16.9116.6116.7416.9517.00
NP After MI And SOA Margin (%) 16.8716.6016.7016.9217.00
Return on Networth / Equity (%) 21.5520.0620.1118.0916.77
Return on Capital Employeed (%) 22.9121.7222.1420.2919.01
Return On Assets (%) 13.3313.0913.8412.5911.62
Asset Turnover Ratio (%) 0.790.810.830.731.04
Current Ratio (X) 1.331.661.411.381.28
Quick Ratio (X) 1.071.341.061.010.95
Inventory Turnover Ratio (X) 14.9614.964.734.254.86
Dividend Payout Ratio (NP) (%) 116.9491.4483.5884.68110.20
Dividend Payout Ratio (CP) (%) 103.7481.7775.1475.4197.15
Earning Retention Ratio (%) -16.948.5616.4215.32-10.20
Cash Earning Retention Ratio (%) -3.7418.2324.8624.592.85
Interest Coverage Ratio (X) 40.1746.33128.61123.73102.87
Interest Coverage Ratio (Post Tax) (X) 27.2631.7890.5585.2571.42
Enterprise Value (Cr.) 523601.25525697.75596944.25477659.75566787.00
EV / Net Operating Revenue (X) 8.308.499.859.1112.05
EV / EBITDA (X) 33.0033.9740.7236.4247.09
MarketCap / Net Operating Revenue (X) 8.418.619.939.1812.15
Retention Ratios (%) -16.948.5516.4115.31-10.20
Price / BV (X) 10.7510.4111.959.8111.98
Price / Net Operating Revenue (X) 8.418.619.939.1812.15
EarningsYield 0.020.010.010.010.01

After reviewing the key financial ratios for Hindustan Unilever Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
  • For Diluted EPS (Rs.), as of Mar 25, the value is 45.32. This value is within the healthy range. It has increased from 43.74 (Mar 24) to 45.32, marking an increase of 1.58.
  • For Cash EPS (Rs.), as of Mar 25, the value is 51.21. This value is within the healthy range. It has increased from 48.94 (Mar 24) to 51.21, marking an increase of 2.27.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 210.22. It has decreased from 217.95 (Mar 24) to 210.22, marking a decrease of 7.73.
  • For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.60. It has increased from 263.39 (Mar 24) to 268.60, marking an increase of 5.21.
  • For PBDIT / Share (Rs.), as of Mar 25, the value is 67.52. This value is within the healthy range. It has increased from 65.85 (Mar 24) to 67.52, marking an increase of 1.67.
  • For PBIT / Share (Rs.), as of Mar 25, the value is 61.76. This value is within the healthy range. It has increased from 60.67 (Mar 24) to 61.76, marking an increase of 1.09.
  • For PBT / Share (Rs.), as of Mar 25, the value is 61.37. This value is within the healthy range. It has increased from 59.28 (Mar 24) to 61.37, marking an increase of 2.09.
  • For Net Profit / Share (Rs.), as of Mar 25, the value is 45.44. This value is within the healthy range. It has increased from 43.77 (Mar 24) to 45.44, marking an increase of 1.67.
  • For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.31. This value is within the healthy range. It has increased from 43.73 (Mar 24) to 45.31, marking an increase of 1.58.
  • For PBDIT Margin (%), as of Mar 25, the value is 25.13. This value is within the healthy range. It has increased from 25.00 (Mar 24) to 25.13, marking an increase of 0.13.
  • For PBIT Margin (%), as of Mar 25, the value is 22.99. This value exceeds the healthy maximum of 20. It has decreased from 23.03 (Mar 24) to 22.99, marking a decrease of 0.04.
  • For PBT Margin (%), as of Mar 25, the value is 22.84. This value is within the healthy range. It has increased from 22.50 (Mar 24) to 22.84, marking an increase of 0.34.
  • For Net Profit Margin (%), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 10. It has increased from 16.61 (Mar 24) to 16.91, marking an increase of 0.30.
  • For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.87. This value is within the healthy range. It has increased from 16.60 (Mar 24) to 16.87, marking an increase of 0.27.
  • For Return on Networth / Equity (%), as of Mar 25, the value is 21.55. This value is within the healthy range. It has increased from 20.06 (Mar 24) to 21.55, marking an increase of 1.49.
  • For Return on Capital Employeed (%), as of Mar 25, the value is 22.91. This value is within the healthy range. It has increased from 21.72 (Mar 24) to 22.91, marking an increase of 1.19.
  • For Return On Assets (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 13.09 (Mar 24) to 13.33, marking an increase of 0.24.
  • For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.81 (Mar 24) to 0.79, marking a decrease of 0.02.
  • For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. It has decreased from 1.66 (Mar 24) to 1.33, marking a decrease of 0.33.
  • For Quick Ratio (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.07, marking a decrease of 0.27.
  • For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.96. This value exceeds the healthy maximum of 8. There is no change compared to the previous period (Mar 24) which recorded 14.96.
  • For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 116.94. This value exceeds the healthy maximum of 50. It has increased from 91.44 (Mar 24) to 116.94, marking an increase of 25.50.
  • For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 103.74. This value exceeds the healthy maximum of 50. It has increased from 81.77 (Mar 24) to 103.74, marking an increase of 21.97.
  • For Earning Retention Ratio (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 40. It has decreased from 8.56 (Mar 24) to -16.94, marking a decrease of 25.50.
  • For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 40. It has decreased from 18.23 (Mar 24) to -3.74, marking a decrease of 21.97.
  • For Interest Coverage Ratio (X), as of Mar 25, the value is 40.17. This value is within the healthy range. It has decreased from 46.33 (Mar 24) to 40.17, marking a decrease of 6.16.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.26. This value is within the healthy range. It has decreased from 31.78 (Mar 24) to 27.26, marking a decrease of 4.52.
  • For Enterprise Value (Cr.), as of Mar 25, the value is 523,601.25. It has decreased from 525,697.75 (Mar 24) to 523,601.25, marking a decrease of 2,096.50.
  • For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 3. It has decreased from 8.49 (Mar 24) to 8.30, marking a decrease of 0.19.
  • For EV / EBITDA (X), as of Mar 25, the value is 33.00. This value exceeds the healthy maximum of 15. It has decreased from 33.97 (Mar 24) to 33.00, marking a decrease of 0.97.
  • For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
  • For Retention Ratios (%), as of Mar 25, the value is -16.94. This value is below the healthy minimum of 30. It has decreased from 8.55 (Mar 24) to -16.94, marking a decrease of 25.49.
  • For Price / BV (X), as of Mar 25, the value is 10.75. This value exceeds the healthy maximum of 3. It has increased from 10.41 (Mar 24) to 10.75, marking an increase of 0.34.
  • For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.41. This value exceeds the healthy maximum of 3. It has decreased from 8.61 (Mar 24) to 8.41, marking a decrease of 0.20.
  • For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Hindustan Unilever Ltd as of February 2, 2026 is: ₹1,828.92

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 2, 2026, Hindustan Unilever Ltd is Overvalued by 22.40% compared to the current share price ₹2,357.00

Intrinsic Value of Hindustan Unilever Ltd as of February 2, 2026 is: ₹1,905.15

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 2, 2026, Hindustan Unilever Ltd is Overvalued by 19.17% compared to the current share price ₹2,357.00

Last 5 Year EPS CAGR: 4.17%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 80.92%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -32.50, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -76.67, which is a positive sign.
  4. The company has higher reserves (25,977.77 cr) compared to borrowings (600.85 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (45.00 cr) and profit (9.38 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Unilever Ltd:
      1. Net Profit Margin: 16.91%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 22.91% (Industry Average ROCE: 29.21%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 21.55% (Industry Average ROE: 23.91%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 27.26
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.07
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 52.4 (Industry average Stock P/E: 53.37)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Hindustan Unilever Ltd. is a Public Limited Listed company incorporated on 17/10/1933 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L15140MH1933PLC002030 and registration number is 002030. Currently Company is involved in the business activities of Manufacture of detergent and similar washing agents excluding soap. Company's Total Operating Revenue is Rs. 61469.00 Cr. and Equity Capital is Rs. 235.00 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Personal CareUnilever House, B D Sawant Marg, Mumbai Maharashtra 400099Contact not found
    Management
    NamePosition Held
    Mr. Nitin ParanjpeChairman & Non-Exe.Director
    Mr. Rohit JawaManaging Director & CEO
    Mr. Ritesh TiwariExecutive Director & CFO
    Mr. Leo PuriIndependent Director
    Ms. Ashu SuyashIndependent Director
    Mr. Ranjay GulatiIndependent Director
    Ms. Neelam DhawanIndependent Director
    Mr. Tarun BajajIndependent Director
    Mr. Biddappa Ponnappa BittiandaExecutive Director

    FAQ

    What is the intrinsic value of Hindustan Unilever Ltd?

    Hindustan Unilever Ltd's intrinsic value (as of 02 February 2026) is ₹1905.15 which is 19.17% lower the current market price of ₹2,357.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,53,763 Cr. market cap, FY2025-2026 high/low of ₹2,660/2,044, reserves of ₹48,481 Cr, and liabilities of ₹82,034 Cr.

    What is the Market Cap of Hindustan Unilever Ltd?

    The Market Cap of Hindustan Unilever Ltd is 5,53,763 Cr..

    What is the current Stock Price of Hindustan Unilever Ltd as on 02 February 2026?

    The current stock price of Hindustan Unilever Ltd as on 02 February 2026 is ₹2,357.

    What is the High / Low of Hindustan Unilever Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Hindustan Unilever Ltd stocks is ₹2,660/2,044.

    What is the Stock P/E of Hindustan Unilever Ltd?

    The Stock P/E of Hindustan Unilever Ltd is 52.4.

    What is the Book Value of Hindustan Unilever Ltd?

    The Book Value of Hindustan Unilever Ltd is 207.

    What is the Dividend Yield of Hindustan Unilever Ltd?

    The Dividend Yield of Hindustan Unilever Ltd is 1.82 %.

    What is the ROCE of Hindustan Unilever Ltd?

    The ROCE of Hindustan Unilever Ltd is 27.8 %.

    What is the ROE of Hindustan Unilever Ltd?

    The ROE of Hindustan Unilever Ltd is 20.7 %.

    What is the Face Value of Hindustan Unilever Ltd?

    The Face Value of Hindustan Unilever Ltd is 1.00.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Hindustan Unilever Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
    Explore More Stocks